Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DOWNERS GROVE, Ill., Jan. 3, 2023 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals
VANCOUVER, BC / ACCESSWIRE / January 3, 2023 / WEX Pharmaceuticals Inc. ("WEX" or the "Company"), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, announced that the first
U.S. carrier United Airlines Holdings Inc said on Tuesday it is currently evaluating the market demand and operating environment to determine when to resume additional flight operations to... | December 27, 2022
Epcoritamab featured in multiple data disclosures, including four oral presentations Results presented from the phase 1b/2 EPCORE NHL-2 trial of epcoritamab combined with standard salvage
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first subject has been dosed in a Phase 1 randomized, placebo-controlled trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics